is semaglutide still in short supply FDA crackdown on off-brand Ozempic products set to take effect, threatening and access for many ⚠️ Weight loss shortcuts can

P R Health Sci J

Food and Drug Administration (FDA) grants a full or conditional approval for Eli Lillys for a drug product whose active ingredient is Eli Lillys retatrutide (including any brand name or identifier such as LY3437943) for any use between market creation and December 31, 2026, 11:59 PM ET

demonstrated that semaglutide had similar effects in an ovariectomized rat model, increasing -catenin expression and reducing RANKL production, which resulted in a net increase in bone formation

Your Next Chapter in 3 Simple Steps Tell us about your preferences, goals, and health to create your personal formula and treatment plan